Weight Loss and Treatment Patterns in a Real World Population of Adults Receiving Saxenda for Weight Management in Routine Clinical Practice in Switzerland
Latest Information Update: 22 Nov 2022
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 16 Nov 2022 Status changed from recruiting to completed.
- 15 Dec 2021 Status changed from not yet recruiting to recruiting.
- 15 Dec 2021 New trial record